149 related articles for article (PubMed ID: 14565168)
1. Inflammation 2003-Sixth World Congress. Anti-inflammatory mechanisms. 2-6 August 2003, Vancouver, Canada.
Braddock M
IDrugs; 2003 Sep; 6(9):841-4. PubMed ID: 14565168
[No Abstract] [Full Text] [Related]
2. Inflammation 2003-Sixth World Congress. 2-6 August 2003, Vancouver, Canada.
Evans R
IDrugs; 2003 Sep; 6(9):831-3. PubMed ID: 14565165
[No Abstract] [Full Text] [Related]
3. Inflammation 2003-Sixth World Congress. Focus on chronic obstructive pulmonary disease. 2-6 August 2003, Vancouver, Canada.
Rossi AG
IDrugs; 2003 Sep; 6(9):838-40. PubMed ID: 14565167
[No Abstract] [Full Text] [Related]
4. Inflammation 2003-Sixth World Congress. Nitric oxide and IBD. 2-6 August 2003, Vancouver, Canada.
Evans R
IDrugs; 2003 Sep; 6(9):834-7. PubMed ID: 14565166
[No Abstract] [Full Text] [Related]
5. International Brain Research Organization--Sixth World Congress of Neuroscience. 10-15 July 2003, Prague, Czech Republic.
Hannan AJ
IDrugs; 2003 Sep; 6(9):852-4. PubMed ID: 14565171
[No Abstract] [Full Text] [Related]
6. Cannabinoids for the treatment of inflammation.
Ashton JC
Curr Opin Investig Drugs; 2007 May; 8(5):373-84. PubMed ID: 17520866
[TBL] [Abstract][Full Text] [Related]
7. International Society of Thrombosis and Hemostasis--XIXth Congress 12-18 July 2003, Birmingham, UK.
Shah S
IDrugs; 2003 Sep; 6(9):858-61. PubMed ID: 14565174
[No Abstract] [Full Text] [Related]
8. Advances in Anti-Inflammatory Therapeutics: 20-21 November 2006, London, UK.
Braddock M
Expert Opin Investig Drugs; 2007 Feb; 16(2):257-61. PubMed ID: 17243946
[TBL] [Abstract][Full Text] [Related]
9. Drug treatment for chronic obstructive pulmonary disease.
Wark P
IDrugs; 2003 Sep; 6(9):874-9. PubMed ID: 12964067
[TBL] [Abstract][Full Text] [Related]
10. Cytokines and inflammation - GTCbio's sixth annual conference.
Falk J
IDrugs; 2008 Apr; 11(4):250-1. PubMed ID: 18379955
[No Abstract] [Full Text] [Related]
11. Techniques: magnetic resonance imaging of the lung provides potential for non-invasive preclinical evaluation of drugs.
Beckmann N; Tigani B; Mazzoni L; Fozard JR
Trends Pharmacol Sci; 2003 Oct; 24(10):550-4. PubMed ID: 14559408
[No Abstract] [Full Text] [Related]
12. Investigational new drugs for the treatment of acute coronary syndrome.
O'Connor CT; Kiernan TJ; Yan BP
Expert Opin Investig Drugs; 2015; 24(12):1557-70. PubMed ID: 26414862
[TBL] [Abstract][Full Text] [Related]
13. Flavonoids: inhibitors of cytokine induced gene expression.
Gerritsen ME
Adv Exp Med Biol; 1998; 439():183-90. PubMed ID: 9781304
[No Abstract] [Full Text] [Related]
14. Investigational agents for rheumatoid arthritis.
Merkel PA; Letourneau EN; Polisson RP
Rheum Dis Clin North Am; 1995 Aug; 21(3):779-96. PubMed ID: 8619099
[TBL] [Abstract][Full Text] [Related]
15. Emerging adenosine receptor agonists: an update.
Gao ZG; Jacobson KA
Expert Opin Emerg Drugs; 2011 Dec; 16(4):597-602. PubMed ID: 22148938
[TBL] [Abstract][Full Text] [Related]
16. 18th American Peptide Symposium. Peptide revolution: genomics, proteomics and therapeutics. 19-23 July 2003, Boston, MA, USA.
Craik D
IDrugs; 2003 Sep; 6(9):855-7. PubMed ID: 14565173
[No Abstract] [Full Text] [Related]
17. CHI's Eighth Annual World Pharmaceutical Congress. Targeting pain with novel therapeutics: Part 1.
Foster K
IDrugs; 2009 Aug; 12(8):478-81. PubMed ID: 19629879
[No Abstract] [Full Text] [Related]
18. Treatment of traumatic brain injury with anti-inflammatory drugs.
Bergold PJ
Exp Neurol; 2016 Jan; 275 Pt 3(Pt 3):367-380. PubMed ID: 26112314
[TBL] [Abstract][Full Text] [Related]
19. Targeting inflammation in the treatment of type 2 diabetes: time to start.
Donath MY
Nat Rev Drug Discov; 2014 Jun; 13(6):465-76. PubMed ID: 24854413
[TBL] [Abstract][Full Text] [Related]
20. New macrolides.
Dalziel C; Turner B
IDrugs; 2006 Nov; 9(11):771-3. PubMed ID: 17096297
[No Abstract] [Full Text] [Related]
[Next] [New Search]
